Enter inventor name

Christophe Tratrat

This inventor holds 102 USPTO granted patents, primarily in CK2 Inhibitors (CPC class A61P35-00). Top assignee: King Faisal University. Active years: 2023-2025.

USPTO Granted Patents = 102

% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 2

Forward Citations = 33(Granted Patents)

Forward Citations (Not Self Cited) = 2(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Al-Ahsa, SA (2023 - 2024)
Hofouf, SA (2023 - 2024)

Company Filing History:

102 out of 820

King Faisal University

patents

Years Active: 2023-2025

Loading Chart...

Areas of Expertise:

CK2 Inhibitors

Pyrimidines

Pyrazoles

Naphthyridines

Isoquinolines

Antibacterial Agents

Carboxylic Acids

Aminopyrimidines

Triazoles

Imidazoles

Pyridines

Pyrrolidines

102 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12286436 - Substituted pyrimido[4,5-b]indoles as CK2 inhibitors (2025-04-29),

2. 12269827 - Substituted pyrazino[1',2′:1,5]pyrazolo[4,3-c][1,6]naphthyridines as CK2 inhibitors (2025-04-08),

3. 12269826 - 7H-pyrido[4',3′:4,5]pyrrolo[2,3-c][1,7]naphthyridine compounds as CK2 inhibitors (2025-04-08),

4. 12258345 - Pyrrolo[3,2-c]isoquinoline-2,3-dione compounds as CK2 inhibitors (2025-03-25),

5. 12240851 - Pyrido[3',4′:4,5]pyrrolo[3,2-c]naphthyridine compounds as CK2 inhibitors (2025-03-04),

6. 12215107 - Pyrazino[1',2′:1,5]pyrazolo[4,3-c] [2,6] naphthyridine compounds as CK2 inhibitors (2025-02-04),

7. 12209089 - Pyrimido[1',6′: 1,5]pyrazolo[4,3-c] [2,7] naphthyridines as CK2 inhibitors (2025-01-28),

8. 12187726 - Imidazo[1,5-a]pyrido[4,3-e]pyrazines as CK2 inhibitors (2025-01-07),

9. 12180218 - Substituted pyrimido[4,5-b]indoles as CK2 inhibitors (2024-12-31),

10. 12180209 - Pyrrolo[3,2-c][2,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors (2024-12-31),

11. 12180208 - Pyrazolo[1,5-c]pyrido[3,4-e]pyrimidines as CK2 inhibitors (2024-12-31),

12. 12173005 - Pyrimido[1',6′:1,5]pyrazolo[4,3-b][1,7]naphthyridine compounds as CK2 inhibitors (2024-12-24),

13. 12173003 - Pyrrolo[3,2-C][2,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors (2024-12-24),

14. 12173001 - Pyrido[3,4-e][1,2,4]triazolo[4,3-c]pyrimidines as CK2 inhibitors (2024-12-24),

15. 12168662 - Pyrido[4',3′:4,5]pyrrolo[2,3-c][2,7]naphthyridines compounds as CK2 inhibitors (2024-12-17),

Title: The Innovative Mind of Christophe Tratrat

Introduction: Christophe Tratrat, a talented inventor hailing from Al-Ahsa, Saudi Arabia, is known for his groundbreaking contributions to the world of inventions and innovations.

Latest Patents: Christophe Tratrat has recently been granted patents for his cutting-edge inventions in the fields of renewable energy technology and sustainable agriculture practices.

Career Highlights: Throughout his illustrious career, Christophe Tratrat has demonstrated a remarkable ability to think outside the box and develop solutions to complex problems. His inventions have not only improved efficiency in various industries but have also had a positive impact on the environment.

Collaborations: Christophe Tratrat has collaborated with leading research institutions and universities around the world to further his innovative projects. His partnerships have led to the development of revolutionary technologies that have the potential to shape the future.

Conclusion: In conclusion, Christophe Tratrat's passion for innovation and his dedication to creating a better world through his inventions make him a true pioneer in his field. His work continues to inspire the next generation of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]